Abstract:OBJECTIVE:Previous studies have proved that lncRNA MIR155 host gene (MIR155HG) is overexpressed in glioma and has elucidated its function. However, its functional role and underlying molecular mechanism in non-small cell lung cancer (NSCLC) are unknown. This study aimed to investigate the function and underlying mechanism of MIR155HG in NSCLC.MATERIALS AND METHODS:Differentially expressed lncRNAs in NSCLC tissue were identified from Gene Expression Omnibus (GEO) database. The expression of MIR155HG, miR-155-3p, miRNA-155-5p, and tumor protein p53-inducible nuclear protein 1 (TP53INP1) in NSCLC specimens and cells were quantified using quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blotting analysis. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and transwell invasion assay were performed to evaluate cell viability and the ability of migration and invasion. Luciferase reporter assay was employed to examine whether miR-155-3p and miR-155-5p could bind to TP53INP1 in NSCLC cells. A xenograft tumor model was used to evaluate the biological function of MIR155HG in vivo.RESULTS:Data obtained from the GEO dataset show that MIR155HG is frequently overexpressed in NSCLC tumor tissues and cell lines. Elevated MIR155HG levels were found to be associated with advanced disease stage and poor prognosis of NSCLC. Cell viability, as well as the capability of migration and invasion of NCI-H1975 and A549 cells, was markedly reduced upon MIR155HG knockdown. Mechanistically, bioinformatics analysis and functional assays confirmed that miR-155-5p and miR-155-3p, two derivatives of MIR155HG, contributed to the effect of MIR155HG in NSCLC. It was also found that miR-155-5p or miR-155-3p mimics could dramatically rescue the inhibition of cell proliferation, migration, and invasion caused by siMIR155HG. Furthermore, bioinformatics analysis and Luciferase reporter assays revealed that miR-155-5p and miR-155-3p mediate the effect of MIR155HG in NSCLC cells by negatively regulating the tumor suppressor TP53INP1.CONCLUSIONS:Current findings indicate that MIR155HG/miR-155 axis facilitates NSCLC progression by downregulating TP53INP1. Therefore, the MIR155HG/miR-155 axis may be a potential therapeutic target for NSCLC.

Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling Via Oncogenes YBX1, MET, and P21 in Lung Cancer.

Supplementary Figure S1-S9 from Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling Via Oncogenes YBX1, MET, and P21 in Lung Cancer

Downregulation of Long Non-Coding RNA MR4435-2HG Suppresses Breast Cancer Progression Via the Wnt/β-catenin Signaling Pathway.

Lncrna MIR22HG-Derived Mir-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity

MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays.

Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers

Prognostic Values of Long Non-Coding RNA MIR22HG for Patients with Hepatocellular Carcinoma after Hepatectomy.

LncRNA MIR22HG Inhibits Growth, Migration and Invasion Through Regulating the Mir‐10a‐5p/ncor2 Axis in Hepatocellular Carcinoma Cells

MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor

The crucial role of LncRNA MIR210HG involved in the regulation of human cancer and other disease

LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression

MIR205HG Facilitates Carcinogenesis of Lung Squamous Cell Carcinoma in Vitro Revealed by Long Noncoding RNA Profiling.

Based on in vivo and in vitro experiments validation: lncRNA MIR210HG inhibits esophageal squamous cell carcinoma and correlates with autophagy and apoptosis

Interfering with Long Non-Coding RNA MIR22HG Processing Inhibits Glioblastoma Progression Through Suppression of Wnt/β-catenin Signalling

Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling.

Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression by Reprogramming Neutrophils.

Long non‐coding RNA MIR31HG as a prognostic predictor for malignant cancers: A meta‐ and bioinformatics analysis

Long Noncoding RNA Mir503hg, a Prognostic Indicator, Inhibits Tumor Metastasis by Regulating the HNRNPA2B1/NF-κB Pathway in Hepatocellular Carcinoma.

Tumor Suppressor Mir-22 Suppresses Lung Cancer Cell Progression Through Post-Transcriptional Regulation of Erbb3

Data from Long Noncoding RNA &Lt;i>mir4435-2Hg</i> Suppresses Colorectal Cancer Initiation and Progression by Reprogramming Neutrophils

Long Non-Coding RNA MIR155HG Knockdown Suppresses Cell Proliferation, Migration and Invasion in NSCLC by Upregulating TP53INP1 Directly Targeted by Mir-155-3p and Mir-155-5p.